Generic Sweden AbOMXSTO: GENI

GENI: Record revenue and EBITDA in Q3 2024, driven by SaaS growth and strong demand

· Issued by Generic Sweden Ab

Record Q3 2024 with 24% revenue growth, highest-ever EBITDA, and improved margins. SaaS product DOCS and RCS pilots drive future growth, with strong demand in core verticals.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Generic Sweden Ab

All Generic Sweden Ab news releases